﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>9</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>09</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Comparison of eight-week and twelve-week corticosteroid treatment regimens in children with idiopathic nephrotic syndrome; A clinical trial</ArticleTitle>
    <FirstPage>e25</FirstPage>
    <LastPage>e25</LastPage>
    <ELocationID EIdType="doi">10.34172/jrip.2020.25</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Emad Momtaz</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6865-7143</Identifier>
      </Author>
      <Author>
        <FirstName>Amin al Sadat</FirstName>
        <LastName>Sharif</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Amri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5722-6279</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jrip.2020.25</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>01</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>03</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Nephrotic syndrome (NS) is the commonest chronic glomerular disease in children. Idiopathic NS can perfectly be controlled using corticosteroids in most instances, but a significant relapse rate of NS is still a major problem. Several treatment protocols are suggested to decrease relapse rate of NS in children. Objectives: The current clinical trial aimed at comparing the relapse rate between two 8- and 12-week steroid treatment regimens. Patients and Methods: In the current non-randomized, clinical trial, a total of 68 children with primary NS were enrolled. Oral prednisolone was administered to 34 patients for eight weeks (2 mg/kg/d and 1.5 mg/kg/alternate-day/each for four weeks) and other 34 patients for 12 weeks (2 mg/kg/d and 1.5 mg/kg/alternate-day/each for six weeks). A one-year followup was completed for all the patients to evaluate relapse rate, steroid resistance, and steroid dependence. Results: The remission rates were 47.1% and 73.5%, respectively in children of the eight- and 12-week treatment groups because the difference was significant (P=0.026). The frequent relapse rates in the eight- and 12-week treatment groups were respectively 26.5% and 11.8%. Steroid dependence rate was 17.6% and 8.8% in the eight- and 12-week treatment groups respectively. The steroid resistance rates were respectively 8.8% and 5.9% in the eight- and 12-week treatment groups. Conclusion: Twelve-week steroid treatment can significantly decrease the relapse rate in comparison with eight-week treatment because no significant difference in steroid resistance, steroid dependence, and frequent relapse between the two treatment protocols was observed. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Nephrotic syndrome</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Children</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Treatment</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>